{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:45:52Z","timestamp":1794717952302,"version":"4.9.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Chromophobe renal cell carcinoma (chRCC) is generally considered an indolent malignancy; however, studies have produced conflicting results regarding the differences among its histologic patterns. The prognostic significance of eosinophilic morphology in chRCC remains controversial, in part due to inconsistent diagnostic criteria and inclusion of morphologic mimickers. Cases were classified by 3 expert genitourinary pathologists into eosinophilic, classic, and mixed chRCC patterns based on strict morphologic and immunohistochemical criteria (n=110). Clinicopathologic features, copy number variations (CNVs), and targeted sequencing of\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">RB1<\/jats:italic>\n                    were assessed, along with pathway analyses using RNAseq and multiplex gene expression profiling. Clinicopathological and survival analysis were assessed using GraphPad Prism. The final cohort included 24 eosinophilic, 47 classic, and 39 mixed chRCC. CNV frequencies were similar across patterns, while RB1 aberrations and enrichment of oncogenic pathways (TP53, PTEN, RB1, DNA repair, mTOR, and cell cycle) were increased in both mixed and eosinophilic chRCC, with the greatest prominence in eosinophilic chRCC. Clinically, eosinophilic chRCC and mixed chRCC were associated with larger tumour size, more advanced clinical stage, and significantly worse disease-free survival (DFS) and overall survival (OS) compared with classic chRCC. On multivariate analysis, histologic pattern and stage remained prognostic of DFS. Therefore, eosinophilic chRCC showed a distinct molecular phenotype with enriched oncogenic pathways and poorer outcomes, while mixed chRCC displayed an intermediate but similarly aggressive profile. These findings indicate that eosinophilic morphology has potentially more aggressive biology than classic chRCC, underscoring the need for the introduction of specific diagnostic criteria for eosinophilic chRCC and its differentiation clinically.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002560","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:12:04Z","timestamp":1776946324000},"page":"894-905","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Eosinophilic Pattern of Chromophobe Renal Cell Carcinoma is More Aggressive Than the Classic Pattern"],"prefix":"10.1097","volume":"50","author":[{"given":"Abraam","family":"Zakhary","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent F.P.","family":"Castillo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[{"name":"Diagnostic and Molecular, Alberta Precision Laboratories and University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Plant","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashiat","family":"Mimosa","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Patel","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"El-Mallah","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Downes","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Yousef","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Division of Pathology, University Health Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Pace","sequence":"additional","affiliation":[{"name":"Division of Urology, St. Michael\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Hamdani","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Unity Health Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola M.","family":"Saleeb","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital"},{"name":"Department of Laboratory Medicine, Unity Health Toronto"},{"name":"Ontario Institute for Cancer Research, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"R1-20260715","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"R2-20260715","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"R4-20260715","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1464-410X.2011.10690.x","article-title":"Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series","volume":"110","author":"Volpe","year":"2012","journal-title":"BJU Int"},{"key":"R5-20260715","doi-asserted-by":"crossref","first-page":"e176743","DOI":"10.1172\/jci.insight.176743","article-title":"Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma","volume":"9","author":"Kapur","year":"2024","journal-title":"JCI Insight"},{"key":"R6-20260715","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAP.0000000000000341","article-title":"Updates in grading of renal cell carcinomas beyond clear cell renal cell carcinoma and papillary renal cell carcinoma","volume":"29","author":"Paner","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R7-20260715","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1097\/PAS.0b013e3181831e68","article-title":"Chromophobe renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases","volume":"32","author":"Amin","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R9-20260715","doi-asserted-by":"crossref","first-page":"103287","DOI":"10.1016\/j.critrevonc.2021.103287","article-title":"Comprehensive review of chromophobe renal cell carcinoma","volume":"160","author":"Garje","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"R11-20260715","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/cancers11101492","article-title":"Classic chromophobe renal cell carcinoma incurs a larger number of chromosomal losses than seen in the eosinophilic subtype","volume":"11","author":"Ohashi","year":"2019","journal-title":"Cancers"},{"key":"R12-20260715","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.3800286","article-title":"Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma","volume":"18","author":"Brunelli","year":"2005","journal-title":"Mod Pathol"},{"key":"R13-20260715","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.21873\/anticanres.14708","article-title":"The role of genetic analysis in correct diagnosis of eosinophilic variant of chromophobe renal cell carcinoma","volume":"40","author":"Molnar","year":"2020","journal-title":"Anticancer Res"},{"key":"R14-20260715","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.eururo.2020.10.007","article-title":"Grading chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis","volume":"79","author":"Avulova","year":"2021","journal-title":"Eur Urol"},{"key":"R15-20260715","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00428-020-02900-x","article-title":"FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of the Cancer Genome Atlas transcriptome\u2013based outlier mining and immunohistochemistry","volume":"478","author":"Tong","year":"2021","journal-title":"Virchows Arch"},{"key":"R17-20260715","first-page":"e12041","article-title":"Comparison of Cox proportional hazards regression and generalized Cox regression models applied in dementia risk prediction","volume":"6","author":"Goerdten","year":"2020","journal-title":"Alzheimers Dement"},{"key":"R18-20260715","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1073\/pnas.1009843107","article-title":"Allele-specific copy number analysis of tumors","volume":"107","author":"Van Loo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19-20260715","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1038\/s41467-025-64547-z","article-title":"ClairS-TO: A deep-learning method for long-read tumor-only somatic small variant calling","volume":"16","author":"Chen","year":"2025","journal-title":"Nature Communications"},{"key":"R20-20260715","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"R21-20260715","doi-asserted-by":"crossref","first-page":"e92688","DOI":"10.1172\/jci.insight.92688","article-title":"Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma","volume":"2","author":"Casuscelli","year":"2017","journal-title":"JCI Insight"},{"key":"R22-20260715","doi-asserted-by":"crossref","first-page":"e0179437","DOI":"10.1371\/journal.pone.0179437","article-title":"Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: a systematic review and meta-analysis","volume":"12","author":"Tang","year":"2017","journal-title":"PLoS One"},{"key":"R23-20260715","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.modpat.2024.100472","article-title":"High-grade, nonsarcomatoid chromophobe renal cell carcinoma: a series of 22 cases with novel molecular features on a subset","volume":"37","author":"Baraban","year":"2024","journal-title":"Mod Pathol"},{"key":"R24-20260715","doi-asserted-by":"crossref","first-page":"102361","DOI":"10.18632\/oncotarget.21971","article-title":"Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"R25-20260715","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1038\/s41379-020-0607-z","article-title":"Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome","volume":"33","author":"Roldan-Romero","year":"2020","journal-title":"Mod Pathol"},{"key":"R26-20260715","doi-asserted-by":"crossref","first-page":"101987","DOI":"10.1016\/j.toxrep.2025.101987","article-title":"PTEN-mediated resistance in cancer: from foundation to future therapies","volume":"14","author":"Tufail","year":"2025","journal-title":"Toxicol Rep"},{"key":"R27-20260715","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"R28-20260715","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2020.07.003","article-title":"Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinico-pathological and genomic profiling","volume":"104","author":"Liu","year":"2020","journal-title":"Human Pathology"},{"key":"R29-20260715","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1464-410X.2002.02977.x","article-title":"Prognostic implications of histological features in patients with chromophobe cell renal carcinoma","volume":"90","author":"Onishi","year":"2002","journal-title":"BJU Int"},{"key":"R30-20260715","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1309\/VLV6-BRTR-HY5B-H485","article-title":"Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients","volume":"118","author":"Lohse","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R31-20260715","first-page":"1","article-title":"Validation of novel grading schemes and refinement of the Leibovich risk groups for chromophobe renal cell carcinoma","volume":"43","author":"Lin","year":"2025","journal-title":"World J Urol"},{"key":"R32-20260715","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00428-019-02710-w","article-title":"Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme","volume":"476","author":"Ohashi","year":"2020","journal-title":"Virchows Arch"},{"key":"R34-20260715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2053168018769510","article-title":"A warning on separation in multinomial logistic models","volume":"5","author":"Cook","year":"2018","journal-title":"Research and Politics"},{"key":"R35-20260715","author":"Banerjee"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:14:27Z","timestamp":1786036467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002560"}},"subtitle":["A Comprehensive Morphologic and Genomic Analysis"],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002560","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}